2021-2022 PDMP Annual Report

Prescription Drug Monitoring Program Annual Report | 2021-22 11 Outcomes Annually the Department reports on outcome-targeted performance measures to the Governor, the President of the Senate, and the Speaker of the House of Representatives as required in section 893.055(14), Florida Statutes. This report contains information on the PDMP’s operation, including basic program and system metrics, the status of critical operational objectives, and findings from various program evaluation activities. This report's overall goal is to provide information to guide the operation of the PDMP, assess PDMP utilization, answer questions about the impact of PDMP information on clinical practice and patient outcomes, and evaluate the effect of the PDMP on community health. Throughout the report, graphs and tables within performance measures are designed to address one or more of the above outcomes. Color bars will indicate the outcome(s) addressed in the performance measure. OUTCOME 1: Reduction of the rate of inappropriate use of controlled substances through Department education and safety efforts. Figures: 3, 11 OUTCOME 2: Reduction of the quantity of controlled substances obtained by individuals engaged in fraud and deceit. Tables: 1, 2 / Figures: 1, 2, 3, 9, 10, 11 OUTCOME 4: Involvement in stakeholders achieving improved patient health care and safety and reduction of controlled substance abuse and diversion. Table: 5 / Figures: 10, 11, 12 OUTCOME 3: Increased coordination among partners participating in the prescription drug monitoring program. Tables: 3,4,5 / Figures: 4, 5, 6, 7 OUTCOME 1 OUTCOME 2 OUTCOME 3 OUTCOME 4